2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
- Study type
- Clinical guideline
- Study name
- ESC Cardio-Oncology 2022
- Design
- Clinical (practice) guideline of the European Society of Cardiology. Details of the development method are given in the full text of the paper.
- Source
- European Heart Journal · 2022
In plain words
This guideline was developed by the European Society of Cardiology together with several specialist cancer and heart societies, and covers heart care for people with cancer. The full text is written for doctors. If you have cancer or are receiving cancer treatment and are worried about your heart health, talk to your treating doctor or a cardiologist.
Study population
The PubMed record has no abstract and contains no information on the target population of the guideline. Details are in the full text of the paper.
Endpoints
Not applicable to a guideline or not stated in the PubMed record. Details are in the full text of the paper.
Safety and side effects
Not stated in the PubMed record. Details are in the full text of the paper.
Clinical significance and place in guidelines
The PubMed record has no abstract, so the clinical impact or specific recommendations of the guideline cannot be extracted from it. By its title, this document is the official European Society of Cardiology guideline on cardio-oncology. The exact content of the recommendations and their levels of evidence should be checked in the full text. An erratum for this paper has also been published in Eur Heart J. 2023;44(18):1621.
Limitations
This card is based only on the PubMed record, which has no abstract. The recommendations, levels of evidence and methodological details should be extracted and verified from the full text of the guideline and its erratum.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.